≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Mantle cell lymphoma, including Hilmo

Endpoint Browser PheWeb

C3_MANTLE_CELL_LYMPHOMA_WIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C83.1
  • Cause of death: ICD-10 — C83.1
  • Cancer registry: Topography ICD-O-3 — ANY
  • Cancer registry: Morphology ICD-O-3 — 9673
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

533

4. Check minimum number of events

None

533

5. Include endpoints

None

533

6. Filter based on genotype QC (FinnGen only)

514

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 514 147 367
Unadjusted period prevalence (%) 0.14 0.05 0.17
Median age at first event (years) 68.62 66.60 69.43

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
533
Matched controls
5330
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
307.7
530
*
XW000
NOMESCO Finland
Bone marrow biopsy
83.9
307.7
267
63
WW500
NOMESCO Finland
Blood transfusion
82.3
307.7
198
38
A03FA01
ATC
metoclopramide; systemic, rectal
27.3
307.7
331
302
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
9246.0
307.7
452
*
JN4BD
NOMESCO Finland
Extensive body CT
31.7
304.4
226
121
H02AB02
ATC
dexamethasone; systemic
100.9
290.1
152
21
A04AA01
ATC
ondansetron; systemic, rectal
58.5
289.7
169
42
L03AA02
ATC
filgrastim; parenteral
4292.4
253.1
224
*
JN6AD
NOMESCO Finland
CT of torso and neck
129.3
252.8
128
13
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
244.1
215
*
M04AA01
ATC
allopurinol; systemic
15.5
236.5
341
548
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
1720.1
233.6
210
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
23.1
227.8
188
123
L03AA13
ATC
pegfilgrastim; parenteral
1563.8
218.8
198
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
38.2
182.7
117
39
JN4AD
NOMESCO Finland
Body CT examination
15.5
182.7
189
182
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
89.8
181.5
96
13
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
163.1
148
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
1026.4
160.3
149
*
ZX120
NOMESCO Finland
Intravenous
13.6
146.3
159
162
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
905.9
145.2
136
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
139.9
128
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
9.0
128.4
210
360
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
23.9
126.6
95
48
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
+∞
119.4
110
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
24.7
111.7
82
39
ZX112
NOMESCO Finland
Subcutaneous
67.5
108.7
60
10
D70.82
ICD-10 Finland
Drug-induced neutropenia
434.7
107.4
104
*
Z51.5
ICD-10 Finland
Palliative care
12.0
106.6
120
126
R50.9
ICD-10 Finland
Fever, unspecified
7.3
105.3
208
428
WZC00
NOMESCO Finland
Treatment plan or consultation
5.9
93.7
284
858
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
91.3
85
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
10.2
89.9
113
137
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
20.9
87.0
68
37
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
81.4
76
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
81.4
76
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
185.0
77.4
79
5
1XC02, ,
NOMESCO Finland
156.4
77.3
80
6
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
37.6
76.4
48
14
XX3DW
NOMESCO Finland
Time consuming IT work
10.0
73.9
92
109
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
73.7
69
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
13.7
73.5
72
60
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
72.6
68
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
101.4
72.2
78
9
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
71.5
67
*
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
+∞
71.5
67
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
762.1
69.7
67
*
H02AB06
ATC
prednisolone; systemic
5.2
67.3
391
1853
J05AB11
ATC
valaciclovir; oral
5.4
65.8
164
402
C61
ICD-10 Finland
Malignant neoplasm of prostate
366.2
65.0
64
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
9.8
62.2
77
90
J01MA12
ATC
levofloxacin; systemic
4.6
60.0
201
622
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
59.5
56
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
59.5
56
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.4
59.2
144
343
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
634.2
58.9
57
*
TGC00
NOMESCO Finland
Bronchial lavation
11.3
58.7
65
65
N02AA05
ATC
oxycodone; systemic
4.7
57.9
180
524
WF002
NOMESCO Finland
Radical radiotherapy
216.4
57.2
58
*
212
Kela drug reimbursment
Gout
11.4
56.5
62
61
9673/3-C77.8
ICD-O-3
Mantle cell lymphoma of lymph nodes of multiple regions
+∞
51.9
49
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
183.5
48.8
50
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
48.7
46
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
112.6
47.7
51
5
390
Kela drug reimbursment
Ibrutinib
+∞
47.6
45
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
46.5
44
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
46.5
44
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
8.1
46.4
66
91
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
65.2
46.3
53
9
WZC30
NOMESCO Finland
Teaching
4.5
45.2
136
379
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
6.2
43.7
82
152
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
87.8
43.7
48
6
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
58.4
41.2
48
9
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
40.1
38
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.6
39.6
42
39
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
39.0
37
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
39.0
37
*
WW409
NOMESCO Finland
Other aferesis
+∞
39.0
37
*
1512
Kela drug reimbursment
Ibrutinib
+∞
39.0
37
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.2
38.8
90
202
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
393.5
37.5
37
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
393.5
37.5
37
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
37.0
356
2027
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
198.4
36.2
37
*
L01EL01
ATC
ibrutinib; oral
+∞
35.8
34
*
116
Kela drug reimbursment
Prostate cancer
+∞
34.8
33
*
JN4CD
NOMESCO Finland
Very extensive body CT
12.4
34.6
35
30
EP1AE
NOMESCO Finland
Neck ultrasound examination
6.9
34.5
56
89
WW402
NOMESCO Finland
Leucoferesis
+∞
32.6
31
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
32.6
31
*
L01AA02
ATC
chlorambucil; oral
+∞
32.6
31
*
ZX108
NOMESCO Finland
Inhalation
46.6
32.3
39
9
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
117.0
31.0
33
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
30.5
29
*
A02BC02
ATC
pantoprazole; systemic
3.4
30.2
424
2845
D70.89
ICD-10 Finland
Neutropenic splenomegaly
53.3
29.7
35
7
WW200
NOMESCO Finland
Immunization
8.8
29.5
38
46
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
29.4
28
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
28.4
27
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
27.8
233
1177
H02AB07
ATC
prednisone; oral
3.4
27.7
118
409
B01AB10
ATC
tinzaparin; parenteral
4.1
27.2
83
229
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.7
26.3
94
290
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
26.3
25
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
6.7
26.1
43
69
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
98.4
25.9
28
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
98.4
25.9
28
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
52.8
25.5
30
6
130
Kela drug reimbursment
Malignant tumour
+∞
25.2
24
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
25.2
24
*
L02AE02
ATC
leuprorelin; implant, parenteral
73.6
25.0
28
*
J01MA14
ATC
moxifloxacin; systemic
3.8
25.0
85
253
GD1AD
NOMESCO Finland
Thorax CT examination
4.5
25.0
66
163
R06AE07
ATC
cetirizine; oral
2.6
24.6
238
1274
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.3
23.5
65
166
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
23.3
158
707
D69.5
ICD-10 Finland
Secondary thrombocytopenia
+∞
23.1
22
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.9
22.8
72
203
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
22.0
21
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
22.0
21
*
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
22.0
21
*
9673/3-C09.9
ICD-O-3
Mantle cell lymphoma of tonsil, NOS
+∞
22.0
21
*
D64.9
ICD-10 Finland
Anaemia, unspecified
3.1
22.0
110
416
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
229.0
21.8
22
*
A07AA02
ATC
nystatin; oral
4.3
21.6
59
149
L02BB03
ATC
bicalutamide; oral
+∞
21.0
20
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
80.1
20.8
23
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
5.7
20.7
40
75
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
19.9
19
*
1AA09, ,
NOMESCO Finland
+∞
19.9
19
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
41.8
19.7
24
6
L01XE27
ATC
[U] ibrutinib
+∞
18.9
18
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
103.7
18.7
20
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.8
18.2
59
169
HA1AA
NOMESCO Finland
X-ray mammography
7.0
18.0
28
42
ZX090
NOMESCO Finland
Other technic of radiotherapy
69.0
17.8
20
*
B72
ICPC
Hodgkin Lymphoma
+∞
17.8
17
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
17.8
17
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
17.8
17
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.1
17.6
31
53
Y77
ICPC
Malignant neoplasm prostate
185.9
17.6
18
*
EMB10
NOMESCO Finland
Tonsillectomy
6.3
17.0
29
48
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
+∞
16.8
16
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
175.3
16.6
17
*
EMA10
NOMESCO Finland
Biopsy of tonsil
175.3
16.6
17
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
5.6
16.1
31
58
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
15.7
15
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
15.7
15
*
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
+∞
15.7
15
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
15.7
15
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
15.7
15
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
15.7
15
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
15.7
15
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
20.0
15.7
23
12
TK800
NOMESCO Finland
Hemodialysis
6.5
15.6
26
42
J05AB01
ATC
aciclovir; systemic
2.4
15.6
132
643
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
164.6
15.6
16
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
7.2
15.4
23
33
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
24.2
15.2
21
9
A41.9
ICD-10 Finland
Sepsis, unspecified
4.3
15.2
40
98
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
46.4
15.1
18
*
WX110
NOMESCO Finland
Infiltration anesthesia
2.1
14.8
366
2692
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
2.2
14.8
154
818
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.0
14.7
43
114
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
14.6
14
*
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
+∞
14.6
14
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
14.6
14
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
14.6
14
*
B02.9
ICD-10 Finland
Zoster without complication
3.2
14.5
63
217
ZXE00
NOMESCO Finland
One hour or less
2.1
14.3
217
1329
A04AD12
ATC
aprepitant; systemic
+∞
13.6
13
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
+∞
13.6
13
*
A79
ICPC
Malignancy NOS
143.5
13.5
14
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.0
13.5
274
1851
A41.8
ICD-10 Finland
Other specified sepsis
5.8
13.5
25
45
J01DB01
ATC
cefalexin; oral
2.4
13.4
437
3504
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
4.2
13.3
36
90
L57.0
ICD-10 Finland
Actinic keratosis
2.9
13.3
69
263
B01AB05
ATC
enoxaparin; parenteral
2.1
13.3
178
1036
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
13.2
140
744
JN3AD
NOMESCO Finland
Abdominal CT examination
2.7
13.1
80
332
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.8
13.0
24
43
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
12.5
12
*
C81.3
ICD-10 Finland
Lymphocyte depleted classical Hodgkin lymphoma
+∞
12.5
12
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
12.5
12
*
115
Kela drug reimbursment
Breast cancer
+∞
12.5
12
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
133.0
12.5
13
*
ZXC50
NOMESCO Finland
Cryotherapy
5.3
12.3
25
49
EBA10
NOMESCO Finland
Operative extraction of tooth
2.9
12.2
63
239
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
12.0
142
785
TQW99
NOMESCO Finland
Other minor procedure on skin
4.0
11.9
35
93
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.0
11.9
35
93
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
47.8
11.9
14
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
15.1
11.9
19
13
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
11.7
216
1393
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
11.7
77
331
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
19.5
11.7
17
9
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
11.5
11
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
11.5
11
*
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
+∞
11.5
11
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
11.5
11
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
11.5
11
*
L01BC06
ATC
capecitabine; oral
+∞
11.5
11
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
11.5
11
*
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
11.5
11
*
UJF32
NOMESCO Finland
Coloscopy
2.0
11.5
153
882
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
11.4
176
1068
127
Kela drug reimbursment
Transplant complication
13.1
11.2
19
15
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.3
11.2
29
70
H02AB09
ATC
hydrocortisone; systemic
8.3
11.2
24
30
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
8.9
11.1
23
27
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
11.0
134
746
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.9
10.9
32
85
J35.1
ICD-10 Finland
Hypertrophy of tonsils
15.9
10.9
17
11
J01MA02
ATC
ciprofloxacin; systemic
1.9
10.9
226
1507
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.1
10.8
23
47
ZZR00
NOMESCO Finland
Flap of skin
28.7
10.8
14
5
R50.8
ICD-10 Finland
Other specified fever
22.0
10.7
15
7
C03CA01
ATC
furosemide; systemic
1.9
10.7
221
1470
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.2
10.5
28
69
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.0
10.5
23
30
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
5.6
10.5
20
37
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
10.5
173
1069
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
10.4
10
*
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
+∞
10.4
10
*
1CX01, ,
NOMESCO Finland
+∞
10.4
10
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
10.4
10
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
10.4
10
*
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
10.4
10
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
10.4
10
*
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
+∞
10.4
10
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
10.4
10
*
B03XA02
ATC
darbepoetin alfa; parenteral
7.7
10.3
23
31
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
5.4
10.2
20
38
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
10.0
190
1224
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.6
9.9
58
235
TGD00
NOMESCO Finland
Needle biopsy of lung
101.8
9.4
10
*
ED1AA
NOMESCO Finland
Mandibular X-ray examination
30.6
9.4
12
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
30.6
9.4
12
*
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
30.6
9.4
12
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
9.4
9
*
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
9.4
9
*
9673/3-C80.9
ICD-O-3
Mantle cell lymphoma of unknown primary site
+∞
9.4
9
*
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
+∞
9.4
9
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
9.4
9
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
9.4
9
*
OAA41
NOMESCO Finland
Health check based on individual needs
+∞
9.4
9
*
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
+∞
9.4
9
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
22.2
9.4
13
6
A05AA02
ATC
ursodeoxycholic acid; oral
10.9
9.3
17
16
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
9.3
169
1069
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
9.2
80
388
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
2.2
9.2
89
451
B01AB04
ATC
dalteparin; parenteral
3.5
9.2
32
96
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.7
9.1
21
46
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.2
9.0
35
113
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
8.2
8.9
19
24
N05CF01
ATC
zopiclone; oral
1.8
8.9
183
1201
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.3
8.8
70
327
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
50.8
8.7
10
*
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
50.8
8.7
10
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.6
8.7
50
201
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
16.6
8.6
13
8
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
3.4
8.5
31
96
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
91.5
8.4
9
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
91.5
8.4
9
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.0
8.4
105
586
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
+∞
8.4
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.4
8
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
8.4
8
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
8.4
8
*
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
+∞
8.4
8
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
+∞
8.4
8
*
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
8.4
8
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
8.4
8
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
8.4
8
*
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
+∞
8.4
8
*
Z2221
NOMESCO Finland
Medical doctor
1.9
8.2
134
815
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
14.8
8.2
13
9
SPAT1153
SPAT
Removal of sutures
1.8
8.2
169
1106
NK6AN
NOMESCO Finland
Total body bone isotope imaging
33.9
8.1
10
*
TPX15
NOMESCO Finland
Removal of vascular injection port
33.9
8.1
10
*
D10.4
ICD-10 Finland
Benign neoplasm: Tonsil
33.9
8.1
10
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
8.1
193
1314
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
10.3
8.1
15
15
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.5
8.0
28
84
TAB00
NOMESCO Finland
Lumbar puncture
3.2
8.0
32
105
Z3231
NOMESCO Finland
Registered nurse
1.8
8.0
140
871
J02AC01
ATC
fluconazole; systemic
1.8
8.0
153
978
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.5
8.0
19
43
N02BE01
ATC
paracetamol; systemic, rectal
2.1
7.9
467
4092
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
8.6
7.9
16
19
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
15.3
7.7
12
8
KCD02
NOMESCO Finland
Transurethral resection of bladder
15.3
7.7
12
8
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
45.7
7.7
9
*
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
25.4
7.6
10
*
XX1AD
NOMESCO Finland
Other CT-examination
81.2
7.4
8
*
B74
ICPC
Malignant neoplasm blood other
+∞
7.3
7
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
C83.59
ICD-10 Finland
Lymphoblastic lymphoma of indeterminate type
+∞
7.3
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.3
7
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
7.3
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
C38.1
ICD-10 Finland
Malignant neoplasm: Anterior mediastinum
+∞
7.3
7
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
7.3
7
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
7.3
7
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
7.3
7
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
7.3
7
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
7.3
7
*
YX9AW, ,
NOMESCO Finland
+∞
7.3
7
*
R05
ICD-10 Finland
Cough
1.9
7.3
113
675
N02AX02
ATC
tramadol; systemic, rectal
1.6
7.2
227
1655
CBA10
NOMESCO Finland
Biopsy of eyelid
20.3
7.2
10
5
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
8.1
7.1
15
19
J12.8
ICD-10 Finland
Other viral pneumonia
12.2
7.1
12
10
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
7.1
7.0
16
23
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.5
6.9
45
192
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.5
6.9
23
67
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
6.8
6.9
16
24
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
4.4
6.8
17
40
N03AX16
ATC
[U] pregabalin
1.8
6.7
115
706
J01CA04
ATC
amoxicillin; systemic
1.7
6.7
399
3382
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
7.0
6.6
15
22
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.5
6.5
40
166
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
70.7
6.4
7
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
70.7
6.4
7
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
70.7
6.4
7
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.2
6.4
25
81
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.5
6.4
41
174
UJF34
NOMESCO Finland
Left colonoscopy
18.3
6.3
9
5
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
+∞
6.3
6
*
9673/3-C16.9
ICD-O-3
Mantle cell lymphoma of stomach, NOS
+∞
6.3
6
*
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
6.3
6
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
6.3
6
*
L01CB01
ATC
etoposide; systemic
+∞
6.3
6
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
+∞
6.3
6
*
R59
ICD-10 Finland
Enlarged lymph nodes
+∞
6.3
6
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
6.3
6
*
JAH21
NOMESCO Finland
Staging laparoscopy
+∞
6.3
6
*
9673/3-C77.3
ICD-O-3
Mantle cell lymphoma of lymph nodes of axilla or arm
+∞
6.3
6
*
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
+∞
6.3
6
*
3AA13, ,
NOMESCO Finland
+∞
6.3
6
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
6.3
6
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
6.3
6
*
6BA02, ,
NOMESCO Finland
+∞
6.3
6
*
9673/3-C77.0
ICD-O-3
Mantle cell lymphoma of lymph nodes of head, face and neck
+∞
6.3
6
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
6.3
6
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
6.3
6
*
9673/3-C77.4
ICD-O-3
Mantle cell lymphoma of lymph nodes of inguinal region or leg
+∞
6.3
6
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
6.3
6
*
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
27.0
6.2
8
*
UKC02
NOMESCO Finland
Cystoscopy
1.8
6.2
96
571
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
7.8
6.2
13
17
WX402
NOMESCO Finland
General anaesthesia
1.8
6.1
96
573
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.0
6.1
27
94
J35.0
ICD-10 Finland
Chronic tonsillitis
4.2
6.1
16
39
G53.0
ICD-10 Finland
Postzoster neuralgia
12.7
6.1
10
8
R4110
NOMESCO Finland
Physiotherapy
1.7
6.0
136
902

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 500 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Proper column names.
  • Show details (e.g. Fisher or Chi-square test, N cases and N controls) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV not working.
  • No filters and sorters.
  • Limited amount of endpoints with TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP Concept
ln(OR) -5y
ln(OR) -1y
ln(OR) -1m
ln(OR) d0
ln(OR) +1m
ln(OR) +1y
ln(OR) +5y
MCC -5y
MCC -1y
MCC -1m
MCC d0
MCC +1m
MCC +1y
MCC +5y
Diffuse lymphoma with large B cells
C83.31 (2000501224)
Simple antiboidy therapy of methastized malignancy
WD405 (2001310688)
Multiple cystostatic therapy of methastized malignancy
WD115 (2001310679)
Demanding cystostatic therapy of methastized malignancy
WD125 (2001310680)
Demanding antibody therapy of methastized malignancy
WD415 (2001310689)
pegfilgrastim; parenteral
L03AA13 (21603856)
Follicular lymphoma grade II
C82.1 (45532946)
Non-follicular (diffuse) lymphoma, unspecified
C83.9 (45542649)
Non-Hodgkin lymphoma, unspecified
C85.9 (45561867)
Chemotherapy session for neoplasm
Z51.1 (45595526)
Non-follicular lymphoma
C83 (45755342)
Lymphoplasmacytic lymphoma
C83.01 (2000501223)
Diffuse non-Hodgkin's large cell lymphoma UNS
C83.39 (2000501229)
Exploration of lymph nodes
PJA10 (2001309626)
Excision of cervical lymph nodes
PJD41 (2001309632)
Cystostatic therapy of methastized malignancy
WD105 (2001310678)
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
117 (2001600117)
filgrastim; parenteral
L03AA02 (21603851)
Malignant neoplasm of prostate
C61 (45547509)
Chronic lymphocytic leukaemia of B-cell type
C91.1 (45600564)
Lymphocytic lymphoma
C83.00 (2000501222)
Excision of inguinal lymph nodes
PJD45 (2001309636)
Demanding cystostatic therapy of methastized malignancy
WD135 (2001310681)
CT of torso and neck
JN6AD (2001310938)
chlorambucil
L01AA02 (21601391)
Morphology [Interpretation] in Bone marrow Narrative
51628-6 (3042111)
Bone marrow Pathology biopsy report
33721-2 (3045142)
Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
48674-6 (3049539)
Mantle cell lymphoma
C83.1 (45542646)
Nodular sclerosis classical Hodgkin lymphoma
C81.1 (45547530)
Generalized enlarged lymph nodes
R59.1 (45563318)
B-cell lymphoma, unspecified
C85.1 (45586056)
Drug-induced neutropenia
D70.82 (2000501376)
Bone marrow biopsy
XW000 (2001310618)
Extensive body CT
JN4BD (2001310899)
Whole body extensive metabolic PET with CT
JN4JR (2001310913)
Extensive CT of torso and neck
JN6BD (2001310939)
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: Unspecified
SMOKING-2-3-0 (2002330113)
granisetron; oral, parenteral, transdermal
A04AA02 (21600494)
Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
1952-1 (3013201)
CD3+CD4+ (T4 helper) cells/cells in Blood
8123-2 (3014037)
CD3+CD4+ (T4 helper) cells [#/volume] in Blood
24467-3 (3028167)
Virus identified in Specimen by Culture
6584-7 (3028433)
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 (3043849)
Chromosome analysis panel by Banding
62355-3 (40765096)
Lymph node Pathology biopsy report
66112-4 (40768795)
Body height measure
50373000 (4177340)
Body mass index
60621009 (4245997)
lipegfilgrastim; parenteral
L03AA14 (43534819)
Enlarged lymph nodes, unspecified
R59.9 (45563319)
Diffuse large B-cell lymphoma
C83.3 (45600549)
Basocellular carcinoma of the skin on another or unspecified part of the face
C44.31 (2000500792)
Pneumonia due to Pneumocystis carinii
J17.3*B59 (2000502585)
Very extensive CT examination of mouth and soft tissues of neck
EN1BD (2001302281)
Hemodialysis
TK800 (2001305768)
Drill biopsy of bone marrow, pelvis
TNE25 (2001307884)
Blood transfusion
WW500 (2001310603)
Simple therapy of methastized malignancy with biomodifiers
WD305 (2001310685)
Palliative radiotherapy
WF004 (2001310703)
Radiotherapy of metastasis
WF049 (2001310705)
Multidisciplinary treatment meeting
WZC20 (2001310890)
Body CT examination
JN4AD (2001310897)
Active surveillance of a diagnosed cancer
XZZ00 (2001311159)
Radiotherapy with large shaped fields - isocentric therapy
ZX012 (2001311468)
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: Unspecified
SMOKING-2-2-0 (2002330110)
Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
78445-4 (21492711)
cyclophosphamide
L01AA01 (21601390)
leuprorelin; implant, parenteral
L02AE02 (21603825)
CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
14135-8 (3001405)
Band form neutrophils/Leukocytes in Blood
26508-2 (3004809)
CD3-CD19+ cells/cells in Blood
15196-9 (3006245)
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 (3007080)
CD3+CD8+ (T8 suppressor) cells/cells in Blood
8101-8 (3007449)
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 (3007844)
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 (3010130)
Toxoplasma gondii IgG Ab [Units/volume] in Serum
8039-0 (3014959)
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 (3015635)
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 (3017918)
Hepatitis B virus core Ab [Presence] in Serum
16933-4 (3021879)
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
9728-7 (3025271)
Toxoplasma gondii IgM Ab [Units/volume] in Serum
8040-8 (3027529)
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 (3042194)
Oncology Clinic/Center
261QX0200X (38004268)
Medical Oncology
90 (38004507)
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 (43055120)
Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
71668-8 (43055361)
Adenocarcinoma, NOS, of prostate gland
8140/3-C61.9 (44499685)
Mantle cell lymphoma of bone marrow
9673/3-C42.1 (44502849)
Basal cell carcinoma, NOS, of skin, NOS
8090/3-C44.9 (44505057)
Localized enlarged lymph nodes
R59.0 (45534459)
Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
E79.0 (45605432)
ibrutinib; oral
L01EL01 (947893)
CD3 cells/Lymphocytes in Blood
90304-7 (1175426)
Donor of other organ or tissue
Z52.89 (2000503767)
Extensive MRI examination of brain with high intensity magnet
AA1CG (2001300116)
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA (2001301913)
Neck ultrasound examination
EP1AE (2001302284)
Doppler ultrasound examination of heart
FM1DE (2001303299)
Abdominal ultrasound examination
JN3AE (2001305555)
Cathetrisation of vein
TPH04 (2001309597)
Transfer of autologic stem cells
WW300 (2001310591)
Leucoferesis
WW402 (2001310601)
Other aferesis
WW409 (2001310602)
Adjuvant radiotherapy
WF003 (2001310702)
Sedation and analgesia
WX002 (2001310758)
General anaesthesia
WX402 (2001310806)
General anesthesia, balanced
WX408 (2001310808)
Excision of bone marrow for transplantation
YNB00 (2001311209)
Collection of stem cells for transplant
YNB10 (2001311211)
Scheduled procedure
ZXD10 (2001311387)
One hour or less
ZXE00 (2001311394)
More than one and less than three hours
ZXE10 (2001311401)
Intravenous
ZX120 (2001311495)
Ibrutinib
1512 (2001600148)
Gout
212 (2001600208)
Ibrutinib
390 (2001600351)
Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
82134-8 (21493195)
Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
80721-4 (21493690)
CD4 cells/Lymphocytes in Specimen
80223-1 (21494815)
ondansetron; oral, parenteral, rectal
A04AA01 (21600493)
poliomyelitis, trivalent, inactivated, whole virus
J07BF03 (21601352)
rubella, live attenuated
J07BJ01 (21601359)
sulfamethoxazole and trimethoprim
J01EE01 (21602961)
Emergency Room and Inpatient Visit
ERIP (262)
Reticulocyte production index
31111-8 (3000012)
B lymphocytes [#/volume] in Blood
11130-2 (3000060)
Morphology [Interpretation] in Blood Narrative
18314-5 (3000093)
Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
30076-4 (3000108)
Pathology report gross observation
24419-4 (3002256)
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29257-3 (3002482)
Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
30075-6 (3005156)
IgG [Mass/volume] in Serum or Plasma
2465-3 (3005719)
Leukocyte morphology finding [Identifier] in Blood
11156-7 (3008757)
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 (3008909)
CD3 cells [#/volume] in Blood
8122-4 (3011412)
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 (3013721)
Leukocytes other/Leukocytes in Blood
26471-3 (3013727)
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 (3014162)
Chloride [Moles/volume] in Serum or Plasma
2075-0 (3014576)
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 (3015322)
Hepatitis C virus Ab [Presence] in Serum
16128-1 (3017143)
pH of Serum or Plasma
2753-2 (3018418)
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 (3019284)
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 (3021347)
Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
29610-3 (3022058)
Colonoscopy Study observation
28023-0 (3022145)
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 (3022250)
Reticulocytes [#/volume] in Blood
14196-0 (3023520)
Complement+Immunoglobulin [Units/volume] in Red Blood Cells
4533-6 (3024403)
CD3-CD16+CD56+ (Natural killer) cells/cells in Blood
8112-5 (3027831)
Reticulocytes/Erythrocytes in Blood
4679-7 (3027945)
IgM [Mass/volume] in Serum or Plasma
2472-9 (3028026)
Hemoglobin [Entitic mass] in Reticulocytes
42810-2 (3029080)
Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
34720-3 (3030558)
Prothrombin time (PT) actual/Normal
5894-1 (3033658)
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 (3040853)
Blood type and Crossmatch panel - Blood
34531-4 (3044640)
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 (3046279)
Epstein Barr virus Ab [Presence] in Serum
49178-7 (3048929)
Bacteria [Presence] in Urine
87829-8 (36304419)
Mantle cell lymphoma of lymph nodes of multiple regions
9673/3-C77.8 (36536260)
Hematology
82 (38004501)
Immunohistochemistry procedure
117617002 (4035726)
CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
54218-3 (40757349)
HTLV I+II Ab panel - Serum
55162-2 (40758292)
Short blood count panel - Blood
55429-5 (40758558)
CBC W Ordered Manual Differential panel - Blood
57782-5 (40760892)
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 (40771025)
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
9680/3-C77.9 (44499593)
Mantle cell lymphoma of lymph node, NOS
9673/3-C77.9 (44500674)
Mantle cell lymphoma of tonsil, NOS
9673/3-C09.9 (44502594)
Secondary thrombocytopenia
D69.5 (45532995)
Other specified disorders of white blood cells
D72.8 (45561931)
Localized swelling, mass and lump, neck
R22.1 (45592412)
Other transplanted organ and tissue status
Z94.8 (45600381)
Cough
R05 (45606792)
HIV 1 and 2 tests - Meaningful Use set
75622-1 (46235355)
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 (46235759)
Office Visit
OMOP4822458 (581477)
Inpatient Visit
IP (9201)
rituximab
L01FA01 (955167)
Myelocytes/Leukocytes in Blood
26498-6 (3017181)
Outpatient Visit
OP (9202)
Promyelocytes/Leukocytes in Blood
26524-9 (3021440)
Metamyelocytes/Leukocytes in Blood
28541-1 (3002179)
Blasts/Leukocytes in Blood
26446-5 (3025159)
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 (3006140)
Urate [Moles/volume] in Serum or Plasma
14933-6 (3026493)
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 (3048816)
Supplier / Service Provider
OMOP5117446 (33004)
Differential panel, method unspecified - Blood
69738-3 (42870588)
Monocytes/Leukocytes in Blood
26485-3 (3019069)
Eosinophils/Leukocytes in Blood
26450-7 (3006504)
Lymphocytes/Leukocytes in Blood
26478-8 (3002030)
Basophils/Leukocytes in Blood
30180-4 (3022096)
Neutrophils [#/volume] in Blood by Automated count
751-8 (3013650)
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 (3013707)
Teaching
WZC30 (2001310891)
Neutrophils/Leukocytes in Blood
26511-6 (3018010)
Monocytes [#/volume] in Blood
26484-6 (3001604)
Eosinophils [#/volume] in Blood
26449-9 (3013115)
Lymphocytes [#/volume] in Blood
26474-7 (3019198)
Basophils [#/volume] in Blood
26444-0 (3006315)
prednisone
A07EA03 (21600655)
prednisone; oral
H02AB07 (21602735)
Bacterial infection, unspecified
A49.9 (45590816)
metoclopramide; oral, parenteral, rectal
A03FA01 (21600484)
ABO and Rh group [Type] in Blood
882-1 (3003694)
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 (3020059)
Medical doctor
Z2221 (2001311556)
Thorax X-ray examination
GD1AA (2001303617)
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 (3020460)
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 (3035995)
Outpatient Hospital
22 (8756)
Albumin [Mass/volume] in Serum or Plasma
1751-7 (3024561)
Calcium [Moles/volume] in Serum or Plasma
2000-8 (3015377)
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 (2001304788)
Otolaryngology
4 (38004449)
Blood group antibody screen [Presence] in Serum or Plasma
890-4 (3001079)
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 (46236098)
Inpatient Hospital
21 (8717)
Magnesium [Moles/volume] in Serum or Plasma
2601-3 (3012095)
enoxaparin; parenteral
B01AB05 (21600976)
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 (3016431)
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 (3002385)
allopurinol; oral, parenteral
M04AA01 (21604131)
Bacteria identified in Blood by Culture
600-7 (3023368)
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 (3038288)
oxycodone; oral, parenteral
N02AA05 (21604260)
levofloxacin; inhalant, oral, parenteral
J01MA12 (21603019)
prednisolone
A07EA01 (21600653)
prednisolone; oral, parenteral
H02AB06 (21602734)
Internal Medicine
11 (38004456)
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 (3043924)
Normoblasts [#/volume] in Blood
715-3 (3021589)
Tissue Pathology biopsy report
66121-5 (40768804)
Granulocytes/Leukocytes in Blood
30395-8 (3035933)
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 (3006923)
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 (40764999)
Upper gastrointestinal surgery
106 (44777669)
Fever, unspecified
R50.9 (45582716)
MCV [Entitic mean volume] in Red Blood Cells
30428-7 (3024731)
Hemoglobin [Mass/volume] in Blood
718-7 (3000963)
Erythrocytes [#/volume] in Blood
26453-1 (3026361)
Platelets [#/volume] in Blood
26515-7 (3007461)
MCH [Entitic mass]
28539-5 (3035941)
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 (3009542)
Leukocytes [#/volume] in Blood
26464-8 (3010813)
FEV1/FVC
19926-5 (3011505)
Forced vital capacity [Volume] Respiratory system
19870-5 (3020158)
FEV1
20150-9 (3024653)
Protein electrophoresis panel - Serum or Plasma
24351-9 (3004588)
Sodium [Moles/volume] in Serum or Plasma
2951-2 (3019550)
Potassium [Moles/volume] in Serum or Plasma
2823-3 (3023103)
Creatinine [Moles/volume] in Serum or Plasma
14682-9 (3020564)
Dentistry
C5 (903277)
pH of Specimen
17433-4 (3019225)
Phosphate [Moles/volume] in Serum or Plasma
14879-1 (3003458)
Emergency Room Visit
ER (9203)
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 (3044938)
dexamethasone; oral, parenteral
H02AB02 (21602730)
Protein [Mass/volume] in Serum or Plasma
2885-2 (3020630)
Gastroenterology
10 (38004455)
nystatin; oral
A07AA02 (21600604)
High resolution CT examination of lungs
GD1DD (2001303632)
Laboratory Visit
OMOP4822461 (32036)
CBC panel - Blood by Automated count
58410-2 (40761511)
Extensive structural and functional ultrasound examination of heart
FM1EE (2001303307)
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 (3003338)
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X (38003841)
tinzaparin; parenteral
B01AB10 (21600981)
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 (3005772)
Glucose [Moles/volume] in Serum or Plasma
14749-6 (3013826)
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 (40765161)
INR in Blood by Coagulation assay
34714-6 (3032080)
Transferrin [Mass/volume] in Serum or Plasma
3034-6 (3004789)
Flexible bronchoscopy
UGC12 (2001303610)
Lactate [Moles/volume] in Serum or Plasma
2524-7 (3014111)
valaciclovir; oral
J05AB11 (21603137)
Thorax X-ray examination outside radiological department
GD1UA (2001303652)
aciclovir; oral, parenteral
J05AB01 (21603131)
Base excess in Venous blood by calculation
1927-3 (3002032)
Carbon dioxide [Partial pressure] in Venous blood
2021-4 (3021447)
Insertion of central venous catheter through external or internal jugular vein
TPH15 (2001309600)
Essential (primary) hypertension
I10 (45591453)
Bacteria identified in Isolate by Culture
43409-2 (3042936)
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 (3019902)
Gas panel - Venous blood
24339-4 (3000991)
Abnormal findings on diagnostic imaging of lung
R91 (45548995)
pantoprazole; oral, parenteral
A02BC02 (21600097)
General Surgery
2 (38004447)
pH of Venous blood
2746-6 (3012544)
omeprazole; oral, parenteral
A02BC01 (21600096)
Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21363-7 (3020565)
Paranasal sinuses X-ray examination in one projection
DM1QA (2001301761)
Treponema pallidum Ab [Presence] in Serum
22587-0 (3019832)
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 (3016771)
cetirizine; oral
R06AE07 (21603497)
Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
50548-7 (3030692)
Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34645-2 (3031478)
Case Management Agency
251B00000X (38004193)
aPTT in Platelet poor plasma by Coagulation assay
14979-9 (3018677)
Zoster without complication
B02.9 (45581143)
cefalexin; oral
J01DB01 (21602870)
Pharmacy visit
OMOP4822462 (581458)
Casts [#/volume] in Urine by Automated count
51483-6 (3030467)
Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23826-1 (3012477)
Standard cardiac ultrasound examination
FM1AE (2001303278)
moxifloxacin; oral, parenteral
J01MA14 (21603021)
Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
41001-9 (3042596)
Treatment plan or consultation
WZC00 (2001310885)
Osmolality of Urine
2695-5 (3026782)
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 (3029187)
Epithelial cells [#/volume] in Urine
30383-4 (3000850)
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 (3026910)
Pneumonia, unspecified
J18.9 (45601123)
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 (3029287)
Erythrocytes [#/volume] in Urine
30391-7 (3002582)
Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
20444-6 (3028369)
Anaemia, unspecified
D64.9 (45600610)
Ferritin [Mass/volume] in Serum or Plasma
2276-4 (3001122)
12 lead EKG panel
34534-8 (3044889)
Urgent procedure
ZXD05 (2001311386)
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 (586526)
Pulmonary Disease
29 (38004472)
Infiltration anesthesia
WX110 (2001310767)
Oral Surgery
19 (38004464)
Extended examination of mouth
SAA03 (2001310276)
Paranasal sinuses X-ray examination without contrast
DM1AA (2001301740)
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 (3001668)
FEV1 --post bronchodilation
20155-8 (3023550)
FEV1/FVC --post bronchodilation
69970-2 (42868459)
FVC percent change Respiratory system
69982-7 (42868471)
FEV1 percent change
69983-5 (42868472)
Excision of other lesion extending through all layers of skin in head or neck
QAE10 (2001309784)
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 (3051552)
Leukocytes [#/volume] in Urine
30405-5 (3018095)
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 (21602863)
Clinic/Center
261Q00000X (38004207)
Bacteria [#/volume] in Urine by Automated count
51480-2 (3031040)
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 (3019800)
Urinalysis macro (dipstick) panel - Urine
24357-6 (3037467)
Removal of sutures
SPAT1153 (2001700254)
Emergency Medicine
93 (38004510)
Telephone prescription or other care instructions
WZB00 (2001310884)
Physiotherapy
R4110 (2001310233)
Infectious Disease
44 (38004484)
Nitrite [Presence] in Urine by Test strip
5802-4 (3021601)
Ketones [Presence] in Urine by Test strip
2514-8 (3035350)
Glucose [Presence] in Urine by Test strip
25428-4 (3009261)
IgA [Mass/volume] in Serum or Plasma
2458-8 (3007164)
metronidazole; oral, rectal
P01AB01 (21604857)
Bacteria identified in Urine by Culture
630-4 (3026008)
Bacteria identified in Stool by Culture
625-4 (3025941)
Urea [Moles/volume] in Serum or Plasma
22664-7 (3020779)
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 (706163)
ciprofloxacin; oral, parenteral
J01MA02 (21603009)
tramadol; oral, parenteral, rectal
N02AX02 (21604298)
EKG study
11524-6 (3013512)
Fungus identified in Specimen by Culture
580-1 (3000494)
Palliative care
Z51.5 (45547323)
amoxicillin; oral, parenteral
J01CA04 (21602823)
fluconazole; oral, parenteral
J02AC01 (21603080)
zopiclone; oral
N05CF01 (21604654)
Acute maxillary sinusitis
J01.0 (45601112)
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 (3029879)
Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
92695-6 (37019628)
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 (3030366)
Laceration/cut
S18 (2002000983)
sulfadiazine and trimethoprim
J01EE02 (21602962)
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 (3030306)
Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection
6521-9 (3009595)
Bronchial lavation
TGC00 (2001303585)
Cardiology
6 (38004451)
pneumococcus, purified polysaccharides antigen
J07AL01 (21601312)
Thorax CT examination
GD1AD (2001303618)
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 (3007628)
Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29591-5 (3016881)
Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7993-9 (3025023)
Oxygen [Partial pressure] in Venous blood
2705-2 (3024354)
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 (3004490)
Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
41009-2 (3038546)
Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
41005-0 (3040359)
Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
41003-5 (3041642)
pneumococcus, purified polysaccharides antigen conjugated
J07AL02 (21601313)
paracetamol; oral, parenteral, rectal
N02BE01 (21604344)
Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
49672-9 (3032699)
Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
29723-4 (3037875)
Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
61366-1 (40764127)
codeine and paracetamol
N02AJ06 (1123647)
Gas panel - Capillary blood
24337-8 (3022313)
Mycobacterium sp identified in Specimen by Organism specific culture
543-9 (3005702)
Campylobacter sp identified in Tissue by Organism specific culture
20740-7 (3006418)
Yersinia sp identified in Stool by Organism specific culture
28549-4 (3014765)
Shigella sp [Presence] in Stool by Culture
82300-5 (42529406)
Ultrasound examination of lower leg veins
PH2AE (2001309451)
Mycobacterium sp identified in Specimen
40699-1 (3042631)
pH of Capillary blood
2745-8 (3009343)
Salmonella sp identified in Stool by Organism specific culture
20955-1 (3004716)
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 (3023024)
calcium (different salts in combination); oral
A12AA20 (21600872)
potassium chloride; oral
A12BA01 (21600877)
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 (3008486)
Parainfluenza type 1 nucleic acid detection
222341000000100 (44790047)
Parainfluenza type 2 nucleic acid detection
222351000000102 (44790048)
Parainfluenza type 3 nucleic acid detection
222361000000104 (44790049)
Parainfluenza type 4 nucleic acid detection
810871000000102 (44806118)
Prostate specific Ag [Mass/volume] in Serum or Plasma
2857-1 (3013603)
Puncture of maxillary antrum
TDM10 (2001301819)
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 (3009201)
Bacteria identified in Skin by Aerobe culture
620-5 (3007853)
doxycycline; oral, parenteral
J01AA02 (21602800)
lorazepam; oral, parenteral, sublingual
N05BA06 (21604571)
Acute upper respiratory infection, unspecified
J06.9 (45562437)
Proteinase 3 Ab [Units/volume] in Serum
6968-2 (3009445)

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
262
190
26.15
307.66
1.7
1.4
—
—
—
0
0
176
17
154.08
307.65
1.9
1.1
—
—
—
0
0
183
50
55.21
307.28
2.1
1.2
—
—
—
0
0
218
105
34.44
306.39
2.0
1.3
—
—
—
0
0
284
376
15.03
225.69
1.8
1.5
—
—
—
0
0
267
339
14.78
217.72
1.7
1.5
—
—
—
0
0
292
461
12.80
200.75
1.9
1.6
—
—
—
0
0
213
281
11.96
164.67
5.4
1.9
8.49
11.34
g/l
9.07
202
262
145
9
220.49
145.87
1.3
1.0
—
—
—
0
0
202
347
8.76
122.81
7.0
3.9
1.17
0.77
%
0.94
163
80
65
17
43.41
107.19
4.0
1.7
0.42
0.80
e9/l
1.70
58
17
93
65
17.12
105.78
1.4
1.3
—
—
—
0
0
355
1214
6.76
104.07
6.8
2.5
341.53
366.15
umol/l
3.93
347
1042
177
335
7.41
96.38
7.4
4.0
0.16
0.09
%
0.81
135
69
172
332
7.17
91.50
7.6
3.8
0.66
0.59
%
0.13
131
81
238
629
6.03
90.96
4.0
1.8
1.71
1.77
%
0.37
227
555
80
57
16.34
89.68
1.3
1.3
145.91
164.02
au/ml
0.55
34
20
251
706
5.83
89.11
7.6
2.5
0.81
0.83
mmol/l
1.94
246
653
143
236
7.91
87.92
3.2
1.3
1.06
1.24
g/l
0.40
132
223
59
22
30.03
87.41
5.7
2.0
28.21
47.24
%
4.57
43
13
203
489
6.09
85.28
3.9
1.9
67.29
66.27
e9/l
0.14
165
369
423
1923
6.81
83.12
13.9
5.4
9.97
9.11
%
5.28
415
1792
422
1920
6.75
82.67
13.7
5.3
2.57
3.02
%
4.11
414
1791
351
1378
5.53
81.93
12.0
5.0
—
—
—
0
0
420
1926
6.57
80.79
13.5
5.4
0.70
0.67
%
0.63
410
1793
423
1969
6.56
79.39
14.0
5.3
30.76
25.81
%
8.39
415
1855
160
348
6.14
74.08
8.3
4.1
0.24
0.00
%
1.68
119
68
431
2119
6.40
73.34
13.3
5.3
0.61
0.62
e9/l
0.49
393
1799
434
2155
6.46
72.70
13.5
5.3
1.96
1.79
e9/l
0.70
406
1884
218
633
5.14
72.28
6.7
5.1
1.10
1.02
mmol/l
3.09
213
578
430
2127
6.29
72.11
13.3
5.3
0.04
0.04
e9/l
3.10
392
1811
410
1970
5.69
70.67
10.4
3.8
34.31
35.36
g/l
3.09
394
1818
443
2270
6.64
70.50
36.6
5.8
3.30
4.45
e9/l
17.68
419
1958
438
2224
6.44
70.45
21.7
3.9
10.05
12.91
umol/l
11.93
431
2104
433
2192
6.20
69.46
14.4
5.3
0.16
0.21
e9/l
10.56
403
1897
330
1361
4.74
68.81
8.7
4.1
—
—
—
0
0
57
47
13.46
58.24
1.6
1.4
—
—
—
0
0
57
47
13.46
58.24
1.6
1.4
—
—
—
0
0
57
47
13.46
58.24
1.6
1.4
—
—
—
0
0
57
47
13.46
58.24
1.6
1.4
—
—
—
0
0
62
8
87.64
56.34
2.5
1.6
44.77
26.25
%
—
62
8
234
864
4.05
53.91
13.2
4.3
—
—
—
0
0
44
27
17.67
52.70
5.8
3.6
—
—
—
0
0
48
35
14.97
52.55
5.4
2.7
48.03
56.93
%
1.18
48
28
297
1331
3.78
50.55
9.1
3.4
7.40
7.40
ph
1.01
238
959
413
2313
4.49
50.13
13.9
6.1
1.21
1.21
mmol/l
0.15
357
1994
62
76
9.10
48.00
2.9
1.5
1.01
0.84
%
0.94
47
56
58
68
9.45
46.44
3.2
1.4
32.83
32.91
pg
0.04
58
68
126
326
4.75
46.13
2.2
1.3
—
—
—
0
0
63
84
8.37
45.52
1.3
1.2
—
—
—
0
0
93
188
5.78
45.28
1.4
1.6
—
—
—
0
0
59
75
8.72
44.30
1.3
1.2
—
—
—
0
0
375
2065
3.75
44.25
12.8
5.7
1.21
1.20
mmol/l
0.38
365
1880
38
27
15.08
42.03
1.4
1.1
—
—
—
0
0
297
1458
3.34
41.31
9.6
2.0
2.33
2.35
mmol/l
1.29
283
1257
57
76
8.28
41.10
4.8
2.2
52.05
59.81
%
2.60
57
76
47
8
64.21
40.98
1.1
1.0
—
—
—
0
0
261
1196
3.32
40.57
2.8
1.6
—
—
—
0
0
130
383
4.17
39.77
2.6
1.6
64.75
66.48
g/l
1.49
125
350
52
66
8.62
39.00
1.3
1.1
342.22
256.45
u/ml
0.44
23
33
34
26
13.90
36.00
1.2
1.0
—
—
—
0
0
47
63
8.09
33.62
2.3
2.8
—
—
—
0
0
330
1879
2.99
32.79
25.4
10.5
0.01
0.00
e9/l
0.59
296
1542
173
690
3.23
32.76
2.2
1.9
—
—
—
0
0
179
742
3.13
31.57
2.5
1.3
1.89
2.90
g/l
7.58
145
432
87
229
4.35
30.50
3.4
1.5
20.31
2.82
ug/l
0.53
68
177
30
26
12.17
29.38
1.1
1.1
—
—
—
0
0
326
1917
2.80
29.21
6.0
2.5
—
—
estimate
—
0
0
45
68
7.14
28.93
1.1
1.1
—
—
—
0
0
104
325
3.73
28.64
1.6
1.1
—
—
—
0
0
35
40
9.29
28.34
1.1
1.2
—
—
—
0
0
457
3265
3.80
28.13
27.8
5.6
82.43
77.76
u/l
1.56
448
3032
199
938
2.79
27.09
6.9
2.1
2.45
2.44
mmol/l
0.79
189
818
252
1339
2.67
27.02
6.4
2.2
—
—
—
0
0
124
463
3.19
25.60
7.6
2.2
7.38
7.75
umol/l
0.07
113
407
134
536
3.00
24.45
1.7
1.5
—
—
—
0
0
228
1237
2.47
22.37
21.0
4.2
—
—
—
0
0
236
1301
2.46
22.35
4.0
3.0
0.27
0.48
e6/l
1.52
192
952
261
1515
2.42
21.91
4.2
3.1
22.68
111.61
e6/l
1.21
214
1158
180
898
2.52
20.92
3.2
2.7
548.32
542.80
mosm/kgh2o
0.12
160
776
34
54
6.66
20.79
1.1
1.1
—
—
—
0
0
201
1058
2.44
20.76
3.1
2.4
4.41
4.55
e6/l
0.04
184
960
347
2328
2.41
20.36
16.7
18.4
1.26
1.36
inr
2.71
301
1959
75
235
3.55
20.27
2.0
1.7
1.59
1.55
g/l
0.14
62
210
127
552
2.71
19.43
4.9
3.0
1.89
2.03
mmol/l
0.18
112
476
272
1672
2.28
19.23
5.1
3.7
85.79
119.23
e6/l
0.40
220
1189
92
339
3.07
19.07
10.0
3.5
1.23
1.22
mmol/l
0.97
87
283
110
453
2.80
18.62
9.7
7.3
—
—
—
0
0
128
572
2.63
18.44
4.7
3.1
7.39
7.39
ph
0.35
81
341
24
9
27.83
17.96
3.9
1.2
27.16
22.59
u/l
—
24
9
390
2840
2.39
17.69
6.5
4.5
2.25
2496.77
e6/l
—
8
52
382
2772
2.33
17.23
9.4
4.7
6.54
6.85
mmol/l
3.07
375
2641
51
141
3.89
16.48
2.0
1.3
2.81
1.41
ratio
1.36
23
85
54
158
3.69
16.09
2.1
1.3
30.42
36.57
mg/l
0.58
43
136
193
1101
2.18
15.62
1.8
1.3
—
—
—
0
0
53
158
3.61
15.35
2.1
1.3
56.72
50.46
mg/l
0.26
44
135
36
82
4.64
14.95
3.1
2.1
232.48
73.56
u/ml
0.32
31
65
135
676
2.34
14.89
3.0
2.6
25.77
23.11
%
0.78
129
627
22
12
19.06
14.80
1.4
1.2
—
—
—
0
0
34
76
4.71
14.44
1.7
2.9
—
—
—
0
0
141
728
2.27
14.43
3.0
2.6
2.06
2.23
g/l
3.27
133
669
56
187
3.23
13.58
1.6
1.2
—
—
—
0
0
204
1255
2.01
13.02
2.3
2.3
2.99
2.74
mg/l
0.92
178
1062
267
1813
1.95
12.70
3.9
3.4
6.18
6.24
ph
0.35
148
1025
108
524
2.33
12.64
5.9
2.6
4.42
4.82
e9/l
0.20
99
442
28
60
4.87
12.49
1.1
1.2
85.60
169.65
miu/ml
—
5
20
312
2266
1.91
11.78
4.6
3.8
0.00
0.00
estimate
-0.00
88
467
144
810
2.07
11.55
3.6
2.8
1.01
1.03
e6/l
0.03
79
431
314
2304
1.88
11.28
4.7
3.8
0.00
0.00
estimate
-0.00
91
475
20
18
11.49
11.13
1.5
1.6
—
—
—
0
0
205
1320
1.90
11.04
4.5
3.2
—
—
—
0
0
313
2310
1.86
10.88
4.8
3.8
0.00
0.01
estimate
0.65
87
446
132
744
2.03
10.41
3.8
3.0
1.11
1.52
e6/l
0.51
66
361
248
1737
1.80
9.91
3.6
3.3
1478.28
1637.25
ng/l
0.34
231
1507
81
384
2.31
9.88
2.0
1.7
393.54
366.95
nmol/l
0.57
76
348
13
5
26.58
9.85
1.1
1.0
—
—
—
0
0
209
1401
1.81
9.60
2.8
2.3
59.30
61.61
u/l
0.12
198
1299
84
410
2.24
9.56
1.4
1.3
—
—
—
0
0
19
37
5.29
9.42
1.2
1.2
—
—
—
0
0
33
100
3.45
9.32
1.3
1.3
240.17
305.98
ug/g
0.80
18
62
262
1895
1.75
9.14
3.8
3.0
376.79
145.60
ug/l
8.19
243
1745
73
344
2.30
9.01
4.8
3.7
7.44
7.41
ph
3.74
68
282
70
326
2.32
8.88
4.8
3.5
—
—
—
0
0
45
171
2.78
8.69
1.4
1.2
—
—
—
0
0
192
1291
1.76
8.50
5.0
3.8
0.00
0.01
estimate
0.50
78
425
98
534
2.02
8.35
2.0
1.7
—
—
—
0
0
73
355
2.22
8.35
4.9
3.7
4.94
5.20
kpa
2.33
73
340
34
114
3.12
8.19
1.5
1.1
—
—
—
0
0
12
7
17.50
8.10
2.9
1.0
—
—
—
0
0
370
3007
1.75
8.04
5.9
4.2
—
2.71
—
0
5
12
8
15.30
7.74
1.4
1.0
—
—
—
0
0
109
634
1.90
7.65
10.2
6.6
7.43
7.41
ph
0.65
65
379
29
93
3.24
7.52
2.8
5.2
2.08
2.70
mmol/l
0.60
16
67
145
927
1.78
7.49
2.1
1.6
2.51
1.40
mg/l
0.82
129
721
7
0
+∞
7.31
1.0
0.0
—
—
—
0
0
24
70
3.54
7.20
1.6
1.4
34.98
26.57
g/l
3.00
24
63
106
623
1.88
7.18
10.1
6.6
1.14
1.03
mmol/l
0.09
86
509
72
375
2.06
6.90
2.0
2.0
0.19
0.20
g/l
0.15
66
340
22
63
3.60
6.78
1.6
1.7
0.39
1.06
g/l
1.84
13
51
18
46
4.01
6.49
1.2
1.3
—
—
—
0
0
192
1372
1.62
6.39
6.9
2.7
40.11
37.92
u/l
0.15
186
1287
13
16
8.30
6.36
3.0
2.1
19.72
3.98
nmol/l
0.43
13
16
70
372
2.02
6.34
3.0
2.1
35.92
35.90
u/l
0.00
53
296
6
0
+∞
6.26
1.0
0.0
—
—
—
0
0
6
0
+∞
6.26
1.0
0.0
—
—
—
0
0
6
0
+∞
6.26
1.0
0.0
—
—
—
0
0
6
0
+∞
6.26
1.0
0.0
—
—
—
0
0
6
0
+∞
6.26
1.0
0.0
—
—
—
0
0
17
32
5.45
6.20
1.1
1.1
—
—
—
0
0
229
1724
1.58
6.04
4.7
3.8
0.00
0.01
estimate
0.78
76
375
29
107
2.81
5.95
3.1
4.1
—
—
—
0
0
16
41
3.99
5.75
1.1
1.1
—
—
—
0
0
49
236
2.19
5.74
5.7
3.9
—
—
—
0
0
54
272
2.10
5.65
4.0
2.8
25.29
25.23
mmol/l
0.06
54
264
18
51
3.62
5.65
1.5
1.4
—
—
—
0
0
463
4159
1.86
5.60
52.9
15.6
23.68
27.17
mg/l
2.11
448
3414
254
1988
1.53
5.47
4.6
4.3
31.98
92.63
ng/l
1.25
223
1568
17
48
3.63
5.36
1.6
1.3
42215.83
171495.23
e6/l
0.53
12
30
24
87
2.84
5.11
1.2
1.2
—
—
—
0
0
12
19
6.43
5.10
1.7
3.0
1276.42
1344.05
u/ml
0.03
12
19
16
36
4.55
5.09
1.8
1.3
2.13
2.84
g/l
—
9
26
16
36
4.55
5.09
1.9
1.3
5.12
6.55
g/l
—
8
26
16
36
4.55
5.09
1.8
1.3
0.27
0.30
g/l
—
9
26
60
329
1.93
4.98
7.1
4.4
—
—
—
0
0
64
366
1.85
4.68
4.0
2.7
116.92
131.29
g/l
4.05
64
357
15
35
4.38
4.66
1.9
1.3
—
—
—
0
0
11
18
6.21
4.62
1.2
1.3
—
—
—
0
0
17
54
3.22
4.52
1.3
2.0
90.55
89.58
%
0.41
17
54
143
1022
1.55
4.51
3.6
4.3
118.66
351.34
ng/l
2.70
127
879
50
268
1.96
4.44
5.1
4.3
36.94
36.88
°c
0.64
50
263
90
587
1.64
4.15
1.3
1.2
—
—
—
0
0
239
1921
1.44
4.14
2.4
2.4
80.15
78.04
nmol/l
0.51
223
1677
55
314
1.84
4.05
11.4
8.2
24.41
24.13
mmol/l
0.28
55
307
7
7
10.11
4.02
1.9
1.0
—
—
—
0
0
23
94
2.51
3.93
1.2
1.2
—
—
—
0
0
37
188
2.04
3.83
2.8
2.0
0.00
4.55
estimate
—
8
55
7
8
8.85
3.78
1.0
1.0
—
—
—
0
0
159
1204
1.46
3.70
4.4
3.3
0.03
0.00
estimate
0.49
69
359
8
12
6.75
3.68
1.1
1.1
—
—
—
0
0
14
46
3.10
3.55
1.6
1.8
1.69
1.32
g/24h
—
8
25
13
42
3.15
3.39
1.0
1.2
—
17.00
—
0
12
145
1853
0.70
3.27
2.2
2.0
1.39
1.32
mmol/l
0.51
116
1523
6
7
8.65
3.27
1.7
1.9
—
—
—
0
0
32
165
2.00
3.21
1.1
1.3
—
—
—
0
0
379
4143
0.71
3.20
6.4
7.4
39.92
40.44
mmol/mol
0.57
350
3846
7
11
6.43
3.19
3.3
1.2
144.71
76.45
nmol/l
—
7
11
77
520
1.56
3.08
1.3
1.3
1133.33
558.77
titre
0.64
12
130
13
41
3.22
3.07
2.5
1.6
2952.84
95.08
u/ml
0.45
13
41
6
8
7.57
3.06
1.3
1.0
—
—
—
0
0
8
16
5.06
3.06
1.0
1.0
753.50
1939.62
miu/ml
—
8
16
308
2676
1.36
3.00
4.2
3.2
66.42
51.10
u/l
1.49
290
2481
5
6
8.40
2.75
2.0
1.3
2.40
2.83
%
—
5
6
12
40
3.05
2.71
1.2
1.3
—
—
—
0
0
13
49
2.69
2.64
1.8
1.4
—
—
—
0
0
12
41
2.97
2.63
1.1
1.1
—
—
—
0
0
10
30
3.38
2.61
1.0
1.7
1.00
13249.64
u/l
—
5
7
146
1805
0.74
2.53
3.5
3.5
65.84
50.04
mg/l
0.26
92
1212
43
265
1.68
2.50
1.3
1.3
657.90
271.39
u/ml
0.39
38
246
15
63
2.42
2.48
3.9
2.4
1.20
1.19
mmol/l
0.34
15
63
15
65
2.35
2.33
3.9
2.4
105.73
105.25
mmol/l
0.16
15
65
15
65
2.35
2.33
3.9
2.4
4.18
4.14
mmol/l
0.20
15
65
31
179
1.78
2.28
2.6
1.7
—
—
—
0
0
152
1839
0.76
2.20
4.3
4.2
24.48
8.11
mg/mmol
0.53
91
1201
23
122
1.93
2.19
4.3
3.1
7.14
7.40
mmol/l
0.24
23
117
8
24
3.37
2.18
1.0
1.1
—
—
—
0
0
402
4288
0.75
2.17
5.4
6.5
2.59
2.53
mmol/l
0.59
358
3938
10
36
2.81
2.14
1.1
1.1
—
—
—
0
0
10
36
2.81
2.14
1.1
1.1
—
—
—
0
0
60
417
1.49
2.13
2.0
2.3
199.86
158.19
ug/g
0.40
50
327
23
124
1.89
2.10
4.0
4.2
—
—
—
0
0
8
25
3.23
2.10
1.0
1.1
—
—
—
0
0
121
956
1.34
2.09
1.8
1.8
1359.75
1153.59
nmol/l
1.31
94
738
153
1838
0.76
2.08
3.4
3.4
6.39
7.87
mmol/l
5.52
128
1549
7
20
3.53
2.06
1.0
1.1
—
—
—
0
0
7
20
3.53
2.06
3.9
2.2
0.86
1.05
index
—
7
20
7
20
3.53
2.06
1.0
1.1
—
—
—
0
0
466
4422
1.43
2.00
49.7
19.9
139.28
139.76
mmol/l
3.62
461
4337
57
399
1.48
1.97
3.1
1.9
0.00
0.00
estimate
-0.00
11
70
7
21
3.36
1.97
2.7
1.6
0.22
0.26
nmol/l
—
7
14
390
4159
0.77
1.92
4.6
5.5
1.32
1.40
mmol/l
3.61
350
3808
466
4430
1.41
1.90
50.4
20.0
4.03
4.02
mmol/l
0.16
461
4339
52
362
1.48
1.86
1.6
1.5
—
—
—
0
0
182
1548
1.27
1.80
2.0
1.7
18.48
19.97
nmol/l
0.76
168
1297
395
4195
0.77
1.78
4.8
5.6
4.40
4.39
mmol/l
0.08
360
3867
6
18
3.36
1.75
1.2
1.3
—
—
—
0
0
6
18
3.36
1.75
1.2
1.4
—
—
—
0
0
105
845
1.30
1.60
1.2
1.3
0.90
1.54
u/ml
0.90
23
230
50
357
1.44
1.59
4.3
4.0
92.83
98.46
ng/l
0.13
39
308
25
153
1.67
1.56
4.7
2.1
2336.36
262.96
mg/l
0.51
11
48
41
288
1.46
1.44
1.2
1.2
—
—
—
0
0
8
161
0.49
1.38
1.0
1.1
—
—
—
0
0
22
136
1.64
1.34
2.4
2.4
115.45
133.39
g/l
4.55
22
112
9
42
2.16
1.34
1.3
1.1
—
—
—
0
0
6
24
2.52
1.30
1.7
2.5
—
—
—
0
0
378
3991
0.82
1.29
4.2
4.7
1.32
1.28
mmol/l
0.36
340
3623
254
2307
1.19
1.24
2.2
2.2
91.36
94.40
pmol/l
0.47
155
1212
13
71
1.85
1.20
4.4
1.6
15.74
28.61
u/ml
0.48
13
71
19
117
1.65
1.19
3.9
3.2
2.82
1.68
index
0.53
11
63
6
26
2.32
1.19
1.3
1.4
262.50
260.10
mu/l
—
6
21
130
1115
1.22
1.16
1.7
1.8
474.22
27223254.65
pmol/l
0.97
109
911
67
533
1.29
1.14
1.9
2.6
6.50
7.58
ug/l
0.20
61
471
27
184
1.49
1.13
1.1
1.2
58.57
126.94
u/ml
—
9
67
467
4511
1.28
1.12
58.2
21.0
89.27
85.24
umol/l
0.98
462
4450
447
4296
1.25
1.12
35.8
14.6
—
—
—
0
0
7
32
2.20
1.08
1.0
1.2
138.29
98.59
pmol/l
—
7
32
10
52
1.94
1.06
1.6
1.6
10.85
10.57
%
—
10
52
6
121
0.49
1.06
1.7
1.9
—
—
—
0
0
9
47
1.93
1.02
1.9
1.5
7.60
8.05
mmol/l
—
9
47
14
220
0.63
0.94
1.6
1.9
3.19
3.44
mmol/l
—
9
175
28
201
1.41
0.93
1.5
1.4
—
—
—
0
0
336
3170
1.16
0.92
4.4
3.8
15.03
14.96
pmol/l
0.17
311
2842
6
28
2.16
0.91
1.0
1.5
30.50
25.12
ng/l
—
6
28
176
1592
1.16
0.84
2.3
2.2
153.22
295.53
u/l
1.88
169
1492
53
650
0.80
0.84
1.4
1.3
27.56
11.36
u/ml
0.41
24
230
8
48
1.68
0.79
4.8
1.8
1511.50
1205.40
mg
—
8
48
5
98
0.51
0.78
1.2
1.4
—
—
—
0
0
119
1053
1.17
0.76
5.3
4.1
1.02
1.02
kg/l
1.01
81
699
32
247
1.31
0.72
2.8
2.5
—
—
—
0
0
467
4560
1.19
0.66
70.0
23.4
194.56
236.04
e9/l
30.96
461
4450
467
4562
1.19
0.65
69.9
23.4
4.05
4.49
e12/l
43.81
459
4430
467
4562
1.19
0.65
71.1
23.9
36.86
40.54
%
38.27
462
4494
467
4563
1.19
0.64
69.9
23.5
6.75
6.86
e9/l
0.21
459
4434
6
101
0.59
0.62
1.0
1.7
—
—
—
0
0
5
86
0.58
0.56
1.2
1.3
1.39
1.48
g/l
—
5
86
134
1454
0.90
0.50
3.3
3.7
—
—
—
0
0
7
47
1.50
0.47
1.1
1.4
—
—
—
0
0
7
48
1.46
0.47
1.7
1.5
13.00
16.55
%
—
7
48
382
3920
0.91
0.42
5.6
4.8
2.14
2.00
mu/l
1.05
357
3554
6
93
0.64
0.42
1.8
1.3
0.94
0.91
g/l
—
6
93
5
32
1.57
0.42
1.2
1.2
—
—
—
0
0
5
33
1.52
0.41
1.2
1.8
19.40
15.61
umol/l
—
5
28
0
18
0.00
0.40
0.0
1.1
—
226.89
—
0
18
413
4214
0.91
0.37
5.5
5.6
5.92
6.13
mmol/l
3.54
377
3816
14
108
1.30
0.35
2.6
2.9
35.57
37.11
umol/l
0.10
14
96
7
54
1.30
0.30
1.4
1.5
—
—
—
0
0
65
709
0.91
0.29
1.5
1.3
29.30
39.28
iu/ml
0.49
20
203
9
77
1.17
0.24
1.1
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
7.5
—
8.14
—
0
11
0
11
0.00
0.21
0.0
1.6
—
15.63
—
0
11
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
33
366
0.90
0.21
3.2
2.7
6.10
6.03
ph
0.20
26
263
0
13
0.00
0.21
0.0
1.1
—
26.54
—
0
13
0
13
0.00
0.21
0.0
6.5
—
5.45
—
0
13
6
52
1.16
0.19
1.2
1.2
—
—
—
0
0
145
1402
1.05
0.16
3.3
2.9
0.74
0.74
ug/l
0.01
101
954
15
130
1.16
0.16
2.7
3.3
0.86
0.83
nmol/l
—
8
106
25
263
0.95
0.05
1.3
1.3
—
—
—
0
0
241
2432
0.98
0.05
5.7
4.3
3.13
2.04
ug/l
0.60
218
2179
17
160
1.06
0.04
24.4
10.9
—
—
—
0
0
18
170
1.06
0.04
2.3
2.1
45.83
43.00
nmol/l
0.21
18
161
22
223
0.99
0.00
2.0
1.9
—
—
—
0
0
12
119
1.01
0.00
1.1
1.1
—
109.17
—
0
12
6
63
0.95
-0.00
1.2
1.3
—
—
nmol/l
—
0
0
6
65
0.92
-0.00
1.2
1.3
0.62
28.98
nmol/l
—
6
60
0
6
0.00
-0.00
0.0
1.0
—
96.00
—
0
6
0
5
0.00
-0.00
0.0
1.4
—
79.20
—
0
5
6
63
0.95
-0.00
1.0
1.0
1.65
1.55
g/l
—
6
56
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
67
0.89
-0.00
1.2
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.6
—
7.47
—
0
9
5
59
0.85
-0.00
1.2
1.5
63.20
70.46
%
—
5
41

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_MANTLE_CELL_LYMPHOMA_WIDE – Mantle cell lymphoma, including Hilmo

GWS hits: 1

This endpoint is excluded (different definition than used in FinnGen).